FDA approves Crestor’s generic rivals, much to Astrazeneca’s dismay The Food and Drug Administration on Wednesday approved several generic versions of the popular cholesterol-lowering drug Crestor, ...

Q. I just had a blood test, and my physician said my HDL cholesterol's low and my LDL is high -- the reverse of what it ought to be. She prescribed a brand-name statin drug, Crestor. When I asked ...

Q. I just had a blood test, and my physician said my HDL cholesterol's low and my LDL is high - the reverse of what it ought to be. She prescribed a brand-name statin drug, Crestor. When I asked about ...

DIN: 10 mg tablet 20 mg tablet 40 mg tablet. Indication — as per As an adjunct to diet, at least equivalent to the Adult Treatment product monograph: Panel III ATP III TLC diet, for the reduction of ...

LONDON, Nov 1 (Reuters) - Anglo-Swedish drugmaker AstraZeneca Plc said on Thursday that Canada's Cobalt Pharmaceuticals was seeking U.S. regulatory permission to sell a generic version of its ...

Can we buy generic crestor 40 mg one day shipping Adjunct to diet in hypertriglyceridemia. Adjunct to diet in primary dysbetalipoproteinemia Type III hyperlipoproteinemia. Adjunct to diet to slow the ...

> AstraZeneca accused nine rivals--including Teva Pharmaceutical Industries--of patent infringement over plans to market copycat versions of the cholesterol-control drug Crestor. Report > Takeda says ...

The U.S. Food and Drug Administration today approved the first generic version of Crestor (rosuvastatin calcium) tablets for the following uses: in combination with diet for the treatment of high ...

AstraZeneca has suffered a setback after an Australian court decided that patents on its blockbuster cholesterol drug Crestor are invalid. AstraZeneca has suffered a setback after an Australian court ...

No more than a few hundred U.S. children have a rare disease characterized by ultrahigh levels of bad cholesterol. Yet to the giant drugmaker AstraZeneca, this small group could be worth billions of ...

Generic Zocor has already turned Merck's anti-cholesterol blockbuster into a cheap commodity that's chipping away at Pfizer's Lipitor empire. Now no fewer than nine generic manufacturers are clamoring ...